Naltrexone does not increase brain and body development in rats

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Opioid receptors play a role in regulating growth and development.
• Naltrexone, an opioid receptor antagonist, has been investigated for its potential effects on growth.
• Early life interventions can have lasting impacts on physiological development.

Purpose of the Study:

• To investigate the effects of early postnatal opioid receptor blockade on growth in two rat strains.
• To determine if prolonged naltrexone administration promotes postnatal growth.

Main Methods:

• Preweanling Long-Evans and Sprague-Dawley rats received daily subcutaneous injections of naltrexone (50 mg/kg) or saline from birth to postnatal day 21.
• Brain and body weights were measured at the end of the treatment period.

Main Results:

• Long-Evans rats treated with naltrexone exhibited significantly lower brain and body weights compared to controls.
• Sprague-Dawley rats showed no significant differences in brain or body weight between naltrexone and saline groups.
• These findings indicate strain-dependent effects of early naltrexone exposure.

Conclusions:

• The hypothesis that prolonged early postnatal opioid receptor blockade enhances growth is disconfirmed.
• Early naltrexone administration may negatively impact growth in certain rat strains.
• Developmental outcomes following opioid receptor blockade are influenced by genetic background.